# Oral Colchicine Combined With Intravitreal Infusion of Dexamethasone, LMW Heparin and 5-FU for Management of Proliferative Vitreoretinopathy (PVR)

> **NCT00370760** · PHASE3 · UNKNOWN · sponsor: **Shahid Beheshti University of Medical Sciences**

## Conditions studied

- Proliferative Vitreoretinopathy

## Interventions

- **DRUG:** oral colchicine, dexamethasone, low molecular weight heparin, 5-FU
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00370760
- **Lead sponsor:** Shahid Beheshti University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-09
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2008-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00370760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00370760, "Oral Colchicine Combined With Intravitreal Infusion of Dexamethasone, LMW Heparin and 5-FU for Management of Proliferative Vitreoretinopathy (PVR)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00370760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*